Global Gastroenterology Market Report and Forecast 2024-2032

The global gastroenterology market was valued USD 46.7 billion in 2023, driven by the rising incidence of gastrointestinal disorders, aging population, advancements in technology has led to market growth across the globe. The market size is anticipated to grow at a CAGR of 5.1% during the forecast period of 2024-2032 to achieve a value of USD 72.9 billion by 2032.

Gastroenterology: Introduction

Gastroenterology is a specialized field of medicine focused on the diagnosis, treatment, and management of disorders related to the digestive system, which includes the esophagus, stomach, small intestine, large intestine, liver, gallbladder, pancreas, and rectum. Gastroenterologists are the medical professionals trained to treat conditions like gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel diseases like Crohn's and ulcerative colitis, liver diseases like hepatitis, and gastrointestinal cancers among other conditions.

Importance in Global Healthcare: With the increase in lifestyle-related disorders, aging populations, and growing awareness about gastrointestinal health, gastroenterology has become an essential component of global healthcare. Digestive disorders are among the leading causes of doctor visits, hospitalizations, and disability worldwide.

Key Trends in the Global Gastroenterology Market

• Increasing Prevalence of GI Disorders: There's a rising global incidence of gastroenterological disorders such as inflammatory bowel disease (IBD), gastroesophageal reflux disease (GERD), and irritable bowel syndrome (IBS), which is driving demand for both diagnostic and therapeutic interventions.
• Advances in Endoscopy: Developments in endoscopic techniques, like capsule endoscopy and endoscopic ultrasound, offer less invasive diagnostic and therapeutic options, improving patient comfort and clinical outcomes.
• Personalized Medicine: Tailoring treatment based on individual patient genetics or specific disease phenotypes, especially in conditions like IBD, is becoming more common. This approach can improve treatment efficacy and reduce side effects.
• Growth of Biologics: The introduction and acceptance of biologics, such as anti-TNF agents, to treat conditions like IBD has revolutionized patient outcomes. The development of newer agents targeting different pathways continues to be a trend.
• Microbiome Research: The gut microbiome, the diverse community of microorganisms residing in the digestive tract, is now recognized as a pivotal factor in gastroenterological health and disease. Therapies targeting the microbiome, including fecal microbiota transplants and probiotics, are gaining traction.

Global Gastroenterology Market Segmentation

The market can be categorised into product type, indications, end user and region.

Market Breakup by Product Type

Drugs

• Proton Pump Inhibitor
• H2 Antihistamine
• Others

Medical Devices

• Endoscopy Devices
• Therapeutic devices
• Others
• Diagnostic Tools
• Others

Market Breakup by Indications

• Inflammatory Bowel Disease (IBD)
• Gastroesophageal Reflux Disease (GERD)
• Colorectal Cancer
• Liver Diseases
• Pancreatic Disorders
• Others

Market Breakup by End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research Institutes
• Others

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Global Gastroenterology Market Overview

The global gastroenterology market represents a significant segment within the healthcare sector, focusing on the diagnosis, treatment, and management of digestive system disorders. These encompass conditions affecting the oesophagus, stomach, small intestine, large intestine (colon), liver, gallbladder, and pancreas. The market usually comprises a mix of large multinational corporations and smaller specialized companies. Mergers, acquisitions, and collaborations are common strategies for growth and expansion.

Regional overview:

North America: Widely recognized as a leading market, fueled by a sophisticated healthcare ecosystem, heightened public awareness, and easy access to cutting-edge treatments.

Europe: Comparable to North America in many respects but distinguishes itself through the variety of healthcare models across its different nations.

Asia Pacific: A burgeoning market characterized by its rapidly expanding healthcare facilities and growing public consciousness about gastrointestinal disorders.

Rest of the World: Comprising areas such as Latin America, the Middle East, and Africa, these markets are in the nascent stages of developing their healthcare infrastructure.

Key Players in the Global Gastroenterology Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in global gastroenterology market are as follows:

• Abbott Laboratories
• Johnson & Johnson
• AbbVie Inc.
• Salix Pharmaceuticals
• GlaxoSmithKline Plc.
• ALLERGAN
• Takeda Pharmaceutical Company Limited
• AstraZeneca
• Astellas Pharma US, Inc.
• Pfizer Inc.

The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.